검색
Recursion Pharmaceuticals Inc
RXRX관심 목록에 추가
4.350USD
+0.300+7.41%
종가 10-28 16:00（ET）
2.59B시가총액
손실P/E TTM
장전 거래 06:21 (ET)4.290USD-0.060-1.38%
장전 거래 06:21 (ET)Recursion Pharmaceuticals Inc 정보 회사
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology and chemistry to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits, scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate silico hypotheses into validated insights and novel chemistry. Its clinical programs in oncology and rare diseases include REC-617, REC-1245, REC-3565 and REC-4539. Its REC-617 is an orally bioavailable, cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced solid tumors. Its REV102 program targets ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), an enzyme implicated in the pathogenesis of HPP.
Recursion Pharmaceuticals Inc 프로필
종목 코드 RXRX
회사 이름Recursion Pharmaceuticals Inc
상장일Apr 16, 2021
CEOKhan (Najat)
직원 수840
유형Ordinary Share
회계 연도 종료Apr 16
주소41S Rio Grande Street
도시SALT LAKE CITY
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호84101
전화13852690203
웹사이트https://www.recursion.com/
종목 코드 RXRX
상장일Apr 16, 2021
CEOKhan (Najat)
Recursion Pharmaceuticals Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Independent Director, Co-Founder
Independent Director, Co-Founder
3.32M
+0.10%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Independent Director, Co-Founder
Independent Director, Co-Founder
3.32M
+0.10%
Dr. David Hallett, Ph.D.
Dr. David Hallett, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
317.61K
-8.39%
Dr. David Hallett, Ph.D.
Dr. David Hallett, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
317.61K
-8.39%
Mr. Ben R. Taylor
Mr. Ben R. Taylor
Chief Financial Officer, President - Recursion UK
Chief Financial Officer, President - Recursion UK
261.25K
-2.07%
Mr. Ben R. Taylor
Mr. Ben R. Taylor
Chief Financial Officer, President - Recursion UK
Chief Financial Officer, President - Recursion UK
261.25K
-2.07%
Mr. Zavain Dar
Mr. Zavain Dar
Independent Director
Independent Director
245.37K
+1.88%
Mr. Zavain Dar
Mr. Zavain Dar
Independent Director
Independent Director
245.37K
+1.88%
Ms. Elaine D. Sun
Ms. Elaine D. Sun
Independent Director
Independent Director
111.61K
+79.22%
Ms. Elaine D. Sun
Ms. Elaine D. Sun
Independent Director
Independent Director
111.61K
+79.22%
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Independent Director, Co-Founder
Independent Director, Co-Founder
3.32M
+0.10%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Independent Director, Co-Founder
Independent Director, Co-Founder
3.32M
+0.10%
Dr. David Hallett, Ph.D.
Dr. David Hallett, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
317.61K
-8.39%
Dr. David Hallett, Ph.D.
Dr. David Hallett, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
317.61K
-8.39%
Mr. Ben R. Taylor
Mr. Ben R. Taylor
Chief Financial Officer, President - Recursion UK
Chief Financial Officer, President - Recursion UK
261.25K
-2.07%
Mr. Ben R. Taylor
Mr. Ben R. Taylor
Chief Financial Officer, President - Recursion UK
Chief Financial Officer, President - Recursion UK
261.25K
-2.07%
자주 묻는 질문
Recursion Pharmaceuticals Inc의 상위 5대 주주는 누구인가요?
Recursion Pharmaceuticals Inc의 상위 5대 주주는 다음과 같습니다: Dr. Dean Y. Li, M.D., Ph.D.
Recursion Pharmaceuticals Inc(RXRX)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Recursion Pharmaceuticals Inc의 주식을 보유한 기관은 총 721곳이며, 이들이 보유한 주식의 총 가치는 약 388.34M로 전체 발행 주식의 74.06%를 차지합니다. 이는 2025Q4 대비 46554673.00 증가한 수치입니다.